<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25328469</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>06</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1555-1377</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>34</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>The Iowa orthopaedic journal</Title>
                <ISOAbbreviation>Iowa Orthop J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The standard one gram dose of vancomycin is not adequate prophylaxis for MRSA.</ArticleTitle>
            <Pagination>
                <MedlinePgn>111-7</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The indications for vancomycin prophylaxis to prevent Methicillin-resistant Staphylococcus aureus (MRSA) surgical site infections are increasing. The recommended dose of vancomycin has traditionally been 1 gram intravenous. However, the increasing prevalence of obesity in our population coupled with increasing resistance of MRSA to vancomycin has resulted in recent recommendations for weight-based dosing of vancomycin at 15 mg/kg. We hypothesize that the standard one gram dose of vancomycin is inadequate to meet the recently recommended dosage of 15 mg/kg.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective chart review on 216 patients who were screened positive for MRSA prior to undergoing elective total joint or spine surgeries between January 2009 to January 2012. All patients were given 1 gram of vancomycin within an hour prior to surgical incision as prophylaxis. Using the revised dosing protocol of 15 mg/kg of body weight for vancomycin, proper dosage was calculated for each patient. These values were then compared to the 1 gram dose given to the patients at time of surgery. Patients were assessed as either underdosed (a calculated weight-based dose &gt;1 gram) or overdosed (a calculated weight-based dose &lt;1 gram). Additionally, we used actual case times and pharmacokinetic equations to determine the vancomycin (VAN) levels at the end of the procedures.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 216 patients who tested positive for MRSA, 149 patients (69%) were determined to be underdosed and 22 patients (10%) patients were determined to be overdosed. The predicted VAN level at the end of procedure was &lt;15 mg/L in 60% of patients with 1 gram dose compared to 12% (p=0.0005) with weight base dose. Six patients developed post-operative MRSA surgical site infections (SSI). Of these six patients; four had strains of MRSA with vancomycin minimum inhibitory concentration of &gt;1.0 mg/L. Based on 1 g dosing, 5/6 patients with MRSA positive SSIs had wound closure levels of &lt;15 mg/L and all six were &lt;20 mg/L.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In settings such as hospitals, where the risk for resistant bacteria, especially MRSA, is high, it is becoming increasingly important to accurately dose patients who require vancomycin. In order to avoid incorrect dosing of vancomycin health care providers must use weight-based dosing.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Catanzano</LastName>
                    <ForeName>Anthony</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>NYU Hospital for Joint Diseases.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Phillips</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>NYU Hospital for Joint Diseases.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dubrovskaya</LastName>
                    <ForeName>Yanina</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>NYU Hospital for Joint Diseases.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hutzler</LastName>
                    <ForeName>Lorraine</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>NYU Hospital for Joint Diseases.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bosco</LastName>
                    <ForeName>Joseph</ForeName>
                    <Initials>J</Initials>
                    <Suffix>3rd</Suffix>
                    <AffiliationInfo>
                        <Affiliation>NYU Hospital for Joint Diseases.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Iowa Orthop J</MedlineTA>
            <NlmUniqueID>8908272</NlmUniqueID>
            <ISSNLinking>1541-5457</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>6Q205EH1VU</RegistryNumber>
                <NameOfSubstance UI="D014640">Vancomycin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019072" MajorTopicYN="N">Antibiotic Prophylaxis</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055624" MajorTopicYN="Y">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014640" MajorTopicYN="N">Vancomycin</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">MRSA</Keyword>
            <Keyword MajorTopicYN="N">spine surgery</Keyword>
            <Keyword MajorTopicYN="N">surgical site infections</Keyword>
            <Keyword MajorTopicYN="N">total joint surgery</Keyword>
            <Keyword MajorTopicYN="N">vancomycin</Keyword>
            <Keyword MajorTopicYN="N">weight based dosing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>6</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25328469</ArticleId>
            <ArticleId IdType="pmc">PMC4127722</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Control Hosp Epidemiol. 1999 Nov;20(11):725-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10580621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Health Syst Pharm. 2013 Feb 1;70(3):195-283</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23327981</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2001 Mar-Apr;7(2):327-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11294734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hosp Infect. 2001 Aug;48(4):267-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11461127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2002 Jun 1;34 Suppl 3:S78-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11988877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2002 Jun 13;346(24):1871-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12063371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2003 Mar 1;36(5):592-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12594640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2003 Feb;9(2):196-203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12603990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1982 Apr;21(4):575-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7081978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 1987 Nov;30(11):1214-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3689459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Orthopedics. 1989 Oct;12(10):1333-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2798242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Rheum Dis. 1992 Aug;51(8):932-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1417116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1993 Mar;37(3):436-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8460912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1995 Jan;171(1):216-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7798667</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Infect Control. 1996 Oct;24(5):380-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8902113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 1998 Oct;54(8):621-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9860149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2005 Dec;5(12):751-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16310147</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Behav. 2005 Dec 15;86(5):599-602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16242735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2006 Apr;57(4):589-608</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16507559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2007 Jul;51(7):2582-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17452488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2007 Oct;60(4):788-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17623693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Control Hosp Epidemiol. 2007 Sep;28(9):1047-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17932825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19106348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2009 Aug 1;49(3):325-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19569969</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2011 Feb 1;52(3):e18-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21208910</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacokinet. 2000 Sep;39(3):215-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11020136</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>